
Sign up to save your podcasts
Or


Nvidia buys chipmaker Arm Holdings in a deal worth $40 billion. Oracle becomes TikTok’s technology partner in the U.S. Gilead Sciences buys cancer treatment-maker Immunomedics for $21 billion. Bill Barker analyzes those stories and discusses the NFL’s opening weekend and AB-InBev cutting in-stadium sponsorships.
By The Motley Fool4.7
16041,604 ratings
Nvidia buys chipmaker Arm Holdings in a deal worth $40 billion. Oracle becomes TikTok’s technology partner in the U.S. Gilead Sciences buys cancer treatment-maker Immunomedics for $21 billion. Bill Barker analyzes those stories and discusses the NFL’s opening weekend and AB-InBev cutting in-stadium sponsorships.

3,218 Listeners

1,710 Listeners

806 Listeners

946 Listeners

517 Listeners

4,359 Listeners

1,633 Listeners

825 Listeners

5,138 Listeners

675 Listeners

9,522 Listeners

1,030 Listeners

345 Listeners

302 Listeners

1,293 Listeners

1,550 Listeners

79 Listeners